Ligand validation:5CVJ

N7I: 4-[(1E)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenol

N7I is a Ligand Of Interest in 5CVJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CVJ_N7I_B_402	20%	7%	0.209	0.813	2.64	2.4	4	9	0	0	100%	1
5CVJ_N7I_D_402	12%	2%	0.346	0.878	3.55	3.19	7	8	3	0	100%	1
5CVJ_N7I_A_402	11%	7%	0.262	0.777	2.9	2.12	5	6	2	0	100%	1
5CVJ_N7I_C_402	9%	9%	0.326	0.821	2.99	1.75	7	2	3	0	100%	1
5CVV_N7I_A_402	20%	4%	0.233	0.832	3.08	2.84	4	9	5	0	100%	1
3TKY_N7I_B_369	2%	24%	0.436	0.673	0.61	2.64	-	4	6	0	100%	1
4EVI_N7I_B_401	91%	47%	0.076	0.961	1.38	0.68	2	-	0	0	100%	1
4E70_N7I_B_1402	89%	48%	0.082	0.96	1.36	0.66	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.